almorexant News
Most Popular almorexant Story
GSK, Actelion put failed sleep drug to rest
GlaxoSmithKline and Actelion have discontinued the development of the insomnia drug almorexant, a dual orexin receptor antagonist, over concerns about patients' tolerance of the drug. GSK inked a Read more...
Latest Headlines
- January 28, 2011
- December 21, 2009
- July 14, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
